
    
      A prospective cohort study will be performed to explore the effect of immunological
      heterogeneity of tumor microenvironment in the short-term outcome and long-term outcome of
      patients with gastric cancer. The evaluation parameters are perioperative clinical efficacy,
      postoperative complications, and 3-year survival and recurrence rates.
    
  